We are live on ! Find out more
NGNE icon

Neurogene
NGNE

66 hedge funds and large institutions have $483M invested in Neurogene in 2024 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 20 increasing their positions, 14 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

43% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 14

38% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 16

10% more funds holding

Funds holding: 60 → 66 (+6)

7.81% more ownership

Funds ownership: 94.39% → 102.2% (+7.8%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

22% less capital invested

Capital invested by funds: $617M → $483M (-$135M)

Holders
66
Holders Change
+6
Holders Change %
+10%
% of All Funds
0.95%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
22
Increased
20
Reduced
14
Closed
16
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$19.1M
2
RI
RTW Investments
New York
+$10.6M
3
APM
Avidity Partners Management
Texas
+$9.25M
4
Deutsche Bank
Deutsche Bank
Germany
+$8.65M
5
State Street
State Street
Massachusetts
+$6.3M

Top Sellers

Rank Fund Capital Flow
1
CAM
Cormorant Asset Management
Massachusetts
-$15.2M
2
ACM
Altium Capital Management
New York
-$5.09M
3
Morgan Stanley
Morgan Stanley
New York
-$4.72M
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$3.19M
5
Jane Street
Jane Street
New York
-$2.79M
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
$50.8M +$19.1M +540,123 +63%
EC
2
EcoR1 Capital
California
$46.3M – – –
SB
3
Samsara BioCapital
California
$46.1M – – –
RI
4
RTW Investments
New York
$39M +$10.6M +301,443 +39%
RG
5
Redmile Group
California
$36.9M +$2.77M +78,411 +8%
GPP
6
Great Point Partners
Connecticut
$36.5M – – –
Janus Henderson Group
7
Janus Henderson Group
United Kingdom
$30.4M +$756K +21,438 +3%
APM
8
Avidity Partners Management
Texas
$26.5M +$9.25M +262,300 +56%
Vanguard Group
9
Vanguard Group
Pennsylvania
$20.5M +$1.98M +56,042 +11%
CC
10
Casdin Capital
New York
$19.1M – – –
BBA
11
Baker Bros. Advisors
New York
$16.6M – – –
ACH
12
ArrowMark Colorado Holdings
Colorado
$14.1M -$1.8M -51,073 -12%
Morgan Stanley
13
Morgan Stanley
New York
$13.9M -$4.72M -133,940 -26%
Deutsche Bank
14
Deutsche Bank
Germany
$12.1M +$8.65M +245,146 +281%
Geode Capital Management
15
Geode Capital Management
Massachusetts
$8.08M +$4.33M +122,748 +124%
State Street
16
State Street
Massachusetts
$7.64M +$6.3M +178,626 +572%
CC
17
Commodore Capital
New York
$7.28M – – –
Adage Capital Partners
18
Adage Capital Partners
Massachusetts
$5.89M -$344K -9,745 -6%
Invesco
19
Invesco
Georgia
$4.87M +$400K +11,330 +9%
CAM
20
Cormorant Asset Management
Massachusetts
$3.91M -$15.2M -431,370 -80%
DCM
21
Driehaus Capital Management
Illinois
$3.72M +$1.99M +56,533 +124%
Walleye Capital
22
Walleye Capital
New York
$3.37M -$295K -8,362 -8%
SC
23
Stempoint Capital
New York
$2.86M +$2.77M +78,601 New
Fidelity Investments
24
Fidelity Investments
Massachusetts
$2.63M +$2.55M +72,286 New
NCM
25
Nantahala Capital Management
Connecticut
$2.63M – – –
1
2 3 4

NGNE Hedge Fund Activity: Q2 2024 in Review

66 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Neurogene (NGNE) for Q2 2024, worth a combined $483M — down 22% from $617M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new NGNE positions and 16 closed out — a net gain of 6 holders — while 20 added to existing stakes and 14 trimmed.

The largest buyer was BlackRock, adding an estimated $19.1M. The largest seller was Cormorant Asset Management, cutting an estimated $15.2M.

  • 66 institutional investors held Neurogene (NGNE) as of Q2 2024, up from 60 in Q1 2024.
  • Funds reported $483M of Neurogene stock for Q2 2024, down 22% quarter-over-quarter.
  • 22 funds opened new Neurogene positions in Q2 2024 and 16 closed out, a net change of +6 holders.
  • The largest Neurogene buyer in Q2 2024 was BlackRock, an estimated $19.1M added.
  • The largest Neurogene seller in Q2 2024 was Cormorant Asset Management, an estimated $15.2M sold.

Based on aggregated 13F filings for Q2 2024.